Animal bio distribution studies fall among the essential research and development investigations of pharmaceutical products. The biological fate of a radio pharmaceutical is usually checked, strictly monitoring its distribution behaviour in laboratory animals. Radioactivity assay and scintigraphic imaging procedures are employed for this purpose taking the advantage of radionuclide associated with the pharmaceutical's molecule. Here we have reviewed the pattern of animal studies for the bio-distribution of radiopharmaceuticals. Different considerations like the sacrifice of animals, dissection and handling of organ, carcasses and excreta, and implementation of necessary measures for biosafety and radiation protection, have been evaluated alongwith the discussion about other important parameters such as preparation of standards, radioactivity counting, calculations and evaluation of the obtained bio-distribution data. Some suggestions have been made to further improve the quality of the current procedures and to explore the possible alternatives of the conventional methods keeping in view the latest developments and modern trends in the quality assurance of nuclear medicine.